Diphtheria, a serious bacterial infection, continues to be a significant public health concern worldwide. This potentially life-threatening disease affects the nose, throat, and sometimes the skin, causing severe respiratory problems and other complications. Despite the availability of effective vaccines, diphtheria outbreaks still occur in various parts of the globe, highlighting the need for ongoing vigilance and comprehensive understanding of this condition.
This guide aims to provide a thorough exploration of diphtheria, covering its historical context and epidemiology, clinical manifestations, diagnostic approaches, and treatment strategies. It also delves into crucial public health measures and prevention techniques to combat the spread of this infectious disease. By examining these aspects, readers will gain valuable insights into the nature of diphtheria and the best practices to manage and prevent its occurrence.
The History and Epidemiology of Diphtheria
Diphtheria has a long and troubling history, with severe recurring outbreaks beginning after 1700. The disease primarily affected children under the age of 5, and until treatment became widely available in the 1920s, the public viewed diphtheria as a death sentence. In the 1880s, Dr. Joseph O’Dwyer developed a method of intubating patients to help them survive the life-threatening phase of diphtheria, but this was eventually eclipsed by progress in medical science.
Historical Outbreaks
Cleveland experienced deadly waves of diphtheria until the late 1920s when immunization became standard practice in large parts of the city. In 1875, the 243-person death toll from diphtheria comprised 8.2% of all reported deaths, with children making up most of the mortalities. By 1938, only a handful of cases were reported due to widespread vaccination efforts.
RELATED: How to Recognize and Treat Different Types of Dermatitis
Global Prevalence
Before the introduction of the diphtheria vaccine and widespread vaccination in the 1930s, cases occurred throughout the world. In 2023, an estimated 84% of children worldwide received the recommended 3 doses of diphtheria-containing vaccine during infancy, but there is wide coverage variation between and within countries. Under vaccination in successive cohorts of children can lead to cases and outbreaks of diphtheria.
Recent Resurgence
Recently, as a result of under vaccination, outbreaks have been occurring with increasing frequency despite the availability of a safe and effective vaccine. The COVID-19 pandemic impacted delivery of routine immunization services and surveillance activities, leaving many children susceptible to vaccine-preventable diseases such as diphtheria. No WHO region is completely free from diphtheria, and areas with low immunization coverage allow the bacteria to circulate, increasing the likelihood of outbreaks and putting all unvaccinated and under vaccinated individuals at risk.
Clinical Manifestations of Diphtheria
The clinical manifestations of diphtheria depend on the site of infection, with respiratory and cutaneous diphtheria being the most common presentations. Symptoms typically appear 2 to 5 days after exposure to the bacteria.
Respiratory Diphtheria
Respiratory diphtheria primarily affects the nose and throat. The hallmark feature is the formation of a pseudomembrane, a thick, gray coating of dead tissue that can obstruct breathing. Other symptoms include:
- Mild fever
- Sore throat
- Swollen glands in the neck
- Weakness
- Difficulty swallowing
- Hoarseness
In severe cases, the pseudomembrane can extend into the larynx and trachea, causing life-threatening airway obstruction.
RELATED: Cauliflower Ear: What You Need to Know About Causes and Treatments
Cutaneous Diphtheria
Diphtheria can also manifest as skin infections, characterized by:
- Slow-healing ulcers with clear edges
- Pain
- Redness
- Swelling
- Scaling or peeling skin
Although cutaneous diphtheria rarely leads to severe complications, it can serve as a reservoir for the bacteria, facilitating the spread of infection.
Systemic Complications
If the diphtheria toxin enters the bloodstream, it can cause systemic complications, including:
- Myocarditis (inflammation of the heart muscle)
- Polyneuropathy (nerve damage)
- Kidney failure
These complications can be life-threatening, with a mortality rate of up to 10% even with treatment. Prompt diagnosis and management are crucial to prevent the progression of the disease and minimize the risk of complications.
Diagnostic Approaches and Treatment Strategies
The diagnosis of diphtheria involves a combination of clinical suspicion and laboratory confirmation. Doctors may suspect diphtheria in a patient presenting with a sore throat, low-grade fever, and a characteristic adherent membrane covering the tonsils and throat. Growth of C. diphtheriae in a laboratory culture of material from the throat membrane confirms the diagnosis. For cutaneous diphtheria, a tissue sample from the infected wound can be tested in a laboratory to check for the presence of the bacteria.
Treatment for diphtheria begins immediately, even before the results of bacterial tests are available. The management of diphtheria includes:
- Administration of diphtheria antitoxin (DAT) as soon as possible after assessing for hypersensitivity to horse serum. Early administration of DAT is critical for survival.
- Establishing the diagnosis through appropriate bacterial cultures.
- Administration of antibiotics such as penicillin or erythromycin.
- Appropriate supportive care, including special attention to maintaining an adequate airway in the presence of laryngeal or extensive pharyngeal membranes and careful monitoring for cardiac rhythm disturbances or other manifestations of myocarditis.
Patients with diphtheria often require hospitalization for treatment. They may be isolated in an intensive care unit because diphtheria can spread easily to anyone not vaccinated against the disease. Strict isolation while the patient is contagious helps prevent the spread of the infection. Careful hand-washing by everyone in the patient’s home is important for limiting the spread of the infection.
Once the patient recovers from diphtheria, they will need a full course of diphtheria vaccine to prevent a recurrence. Unlike some other infections, having diphtheria doesn’t guarantee lifetime immunity. An individual can get diphtheria more than once if not fully vaccinated against it.
Public Health Measures and Prevention
Public health measures play a crucial role in preventing the spread of diphtheria and protecting communities from outbreaks. These measures include vaccination programs, contact tracing, and travel precautions.
Vaccination remains the most effective way to prevent diphtheria. The diphtheria vaccine is usually administered as part of a combination vaccine, such as DTaP (diphtheria, tetanus, and acellular pertussis) for infants and children, and Tdap or Td for adolescents and adults. Vaccination programs aim to maintain high immunization coverage within populations to establish herd immunity and minimize the risk of outbreaks.
In the event of a diphtheria case, contact tracing becomes essential to identify and manage individuals who may have been exposed to the bacteria. Public health authorities work to locate and assess close contacts of the infected person, providing prophylactic antibiotics and vaccinations as needed. This process helps contain the spread of the disease and prevents further transmission.
RELATED: How to Identify and Treat Colitis: A Complete Overview
Travel precautions are also important in preventing the introduction and spread of diphtheria across borders. Travelers visiting areas with a higher risk of diphtheria should ensure that their vaccinations are up to date before departure. Healthcare providers should be aware of the epidemiology of diphtheria in different regions and offer appropriate advice and vaccinations to travelers.
Continued surveillance, prompt reporting of suspected cases, and adherence to public health guidelines are essential in maintaining control over diphtheria. Public health authorities collaborate with healthcare providers, schools, and community organizations to promote awareness, encourage vaccination, and implement necessary control measures during outbreaks.
By prioritizing vaccination programs, conducting thorough contact tracing, and promoting travel precautions, public health measures aim to minimize the impact of diphtheria and protect the health and well-being of individuals and communities worldwide.
Conclusion
Diphtheria remains a significant health concern globally, despite the availability of effective vaccines. This comprehensive guide has shed light on the historical context, clinical manifestations, diagnostic approaches, and treatment strategies for this potentially life-threatening bacterial infection. By understanding the disease’s impact and the importance of vaccination, we can better protect communities and prevent outbreaks.
Public health measures play a crucial role to control and prevent diphtheria. Maintaining high vaccination coverage, conducting thorough contact tracing, and promoting travel precautions are key strategies to minimize the spread of the disease. As we continue to face challenges in global health, ongoing vigilance, education, and collaboration among healthcare providers, public health authorities, and communities are essential to keep diphtheria at bay and safeguard public health worldwide.